Johnson & Johnson Quietly Completes Strategic Pivot, Targeting $50 Billion Cancer Drug Blueprint Jul 29, 2026 Life Science
Can Amgen’s Monthly Obesity Shot Rattle the Eli Lilly-Novo Nordisk Duopoly? Jul 29, 2026 Life Science
Moderna’s Market Value Exceeds Twenty Billion Dollars, Yet Ongoing Operating Losses and Competitive Pressures Continue to Trouble Investors Jul 27, 2026 Life Science
Bristol-Myers Squibb’s High Dividend Temporarily Backed by Financial Support, but Patent Cliff Poses Future Concerns Jul 25, 2026 Life Science
Tenet Healthcare Beats Q2 Expectations, Raises Full-Year Guidance, Sending Stock Up Over 17% Jul 25, 2026 Life Science
Eli Lilly and Intuitive Surgical Are Healthcare Stocks Worth Buying, Thanks to Strong Fundamentals Jul 24, 2026 Life Science
AbbVie Outperforms S&P 500 This Year, With Three Major Long-Term Positive Factors Supporting Future Performance Jul 22, 2026 Life Science
Novo Nordisk Sues Eli Lilly Over ‘Deceptive’ GLP-1 Ads, Stock Impact Seen Limited Jul 21, 2026 Life Science
Cathie Wood’s Ark Invest Bets on Beam Therapeutics, with Multiple Clinical Catalysts Expected to Densely Materialize Over the Next 18 Months Jul 20, 2026 Life Science
Anti-Cancer Upstart’s Stock Surges 125% This Year as Billionaire Druckenmiller Builds Large Position Jul 18, 2026 Life Science
Oral Wegovy Dominates. Is Eli Lilly’s Trillion-Dollar Valuation Still Safe? Jul 17, 2026 Life Science
Raising Dividends for 54 Consecutive Years to Reward Shareholders, Abbott Laboratories’ Diversified Layout Consolidates Its Growth Foundation Jul 17, 2026 Life Science
UnitedHealth Group Stock Rises 37% Year-to-Date, Market Sees Path Back to All-Time Highs Jul 16, 2026 Life Science
